US SEC Filings Daily Market Digest — December 17, 2025

18-12-2025

Waterstone Financial, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core event content unavailable.

• ·Single-item 8-K filing under Item 8.01 (Other Events), likely voluntary disclosure.
• ·No quantitative data (transaction value, shares, financial metrics) or event details disclosed.
• ·Filed via SEC with AccNo 0001437749-25-038299; timing compliance unknown.

18-12-2025

This Form 8-K filing reports under Item 8.01 Other Events on December 18, 2025 (AccNo: 0001104659-25-122587). No specific details on the event, transaction, financial impacts, or quantitative data are disclosed in the provided filing information. Analysis is severely limited by absence of substantive content.

• ·Single-item filing: Item 8.01 Other Events only.
• ·Event date and filing date: December 18, 2025; timing compliance NOT_DISCLOSED.
• ·No core event description, dollar values, or financial metrics provided (all NOT_DISCLOSED).

18-12-2025

Stifel Financial Corp filed an 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Analysis limited to filing structure; content details NOT_DISCLOSED.

• ·Items reported: 7.01 (Regulation FD Disclosure, voluntary) and 9.01 (Financial Statements and Exhibits).
• ·Multi-item filing; timing compliance unknown as event date not specified.
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED.

18-12-2025

FIRST COMMUNITY BANKSHARES INC /VA/ filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, or exhibits are provided in the summary. Analysis is limited; all quantitative and event specifics are NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Event details, dollar values, financial impacts, and timing compliance NOT_DISCLOSED.
• ·No revenue, earnings, balance sheet effects, or guidance changes mentioned.

18-12-2025

NIKE, Inc. filed an 8-K on December 18, 2025, disclosing Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. This is a standard earnings-related disclosure with limited accessible content.

• ·Items reported: 2.02 and 9.01 (multi-item filing)
• ·Event: Financial results (voluntary/mandatory under Item 2.02)
• ·Quantitative data: ALL NOT_DISCLOSED (no numbers, revenues, EPS, etc. mentioned)

18-12-2025

Neuphoria Therapeutics Inc. filed an 8-K on December 18, 2025, reporting under Item 3.01 a notice of delisting or failure to satisfy continued listing rules from the US market. No additional details on reasons, financial impacts, or transaction values are disclosed in the provided filing summary. This event signals potential liquidity and visibility loss for shareholders.

• ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule).
• ·Core event: Delisting notice; all quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.
• ·Sector not specified; no related filings, insider activity, or guidance changes mentioned.

18-12-2025

Ark 21Shares Bitcoin ETF filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement under Item 1.01 and including financial statements/exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Analysis limited to filing structure; critical event details NOT_DISCLOSED.

• ·8-K items: 1.01 (Material Definitive Agreement) and 9.01 (Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed material agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED.
• ·Timing and compliance unknown; no revenue, balance sheet, or market reaction data available.

18-12-2025

Urban One, Inc. filed a Form 8-K on December 18, 2025, reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), changes in directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on transaction terms, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing with unknown core event details.

• ·Multi-item 8-K filing covering material agreement, financial obligation, officer changes, and other events.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Timing compliance and strategic details NOT_DISCLOSED.

18-12-2025

First Bancorp, Inc. (/ME/) filed an 8-K on December 18, 2025, solely under Item 8.01 Other Events. No details on the core event, transaction, or financial impacts are provided in the filing summary. Analysis is severely limited by absence of substantive content.

• ·Single-item 8-K filing: Item 8.01 (Other Events)
• ·Voluntary disclosure; timing compliance (within 4 business days?) unassessable without event date
• ·No quantitative data, financial metrics, or event specifics extracted: all NOT_DISCLOSED

18-12-2025

Drilling Tools International Corp filed an 8-K on 2025-12-18 disclosing an Item 5.02 event for officer changes (departure, election, appointment, or compensatory arrangements). No specific details on position affected, individual, reason, or quantitative data are provided in the summary. Analysis is limited; event appears routine without disclosed materiality.

• ·Item 5.02 filing indicates officer-related change but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Neutral governance signal pending full filing review

18-12-2025

Stabilis Solutions, Inc. filed a Form 8-K on December 18, 2025, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, financial metrics, or transaction specifics are disclosed in the provided filing summary. Analysis is limited to filing structure; full content review required for materiality assessment.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary filing; timing compliance NOT_DISCLOSED
• ·No quantitative data (e.g., transaction value, financial metrics) extracted: all NOT_DISCLOSED

18-12-2025

Allstate Corp filed an 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or exhibits are provided. Quantitative data and event specifics are NOT_DISCLOSED.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under Reg FD; timing compliance cannot be assessed without event date.
• ·Core event, financial impact, and materiality NOT_DISCLOSED due to lack of filing content.

18-12-2025

BLUM HOLDINGS, INC. filed a Form 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details of the disclosure, transaction, or financial data are provided in the filing summary. Analysis is limited to filing structure with all quantitative metrics NOT_DISCLOSED.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary filing under Regulation FD
• ·No core event, dollar values, or financial impacts disclosed

18-12-2025

Cartesian Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change (Item 5.02), amendment to Code of Ethics (Item 5.05), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on positions, reasons, or individuals provided. Quantitative data NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors, but key position, type, and reason NOT_DISCLOSED.
• ·Item 5.05 reports Code of Ethics amendment or waiver, implications unclear without details.
• ·Items 7.01 and 9.01 suggest additional disclosure and exhibits, content NOT_DISCLOSED.

18-12-2025

Mission Produce, Inc. filed an 8-K on December 18, 2025, reporting financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure; full content review required for materiality.

• ·Multi-item 8-K filing: Items 2.02, 7.01, 9.01
• ·Event: Financial results announcement
• ·All quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

18-12-2025

ACV Auctions Inc. filed an 8-K on December 18, 2025 (AccNo: 0001637873-25-000025), reporting under Item 1.01 entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, value, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement), 9.01 (Exhibits)
• ·Multi-item 8-K filing; timing compliance NOT_DISCLOSED
• ·Core event: Material Definitive Agreement; all quantitative data (value, shares, metrics) NOT_DISCLOSED

18-12-2025

FedEx Corp filed an 8-K on December 18, 2025, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure due to lack of substantive content.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Financial results announcement; all quantitative values (revenue, EPS, etc.) NOT_DISCLOSED.
• ·No timing details on event occurrence vs filing (within 4 business days?) or market expectations provided.

18-12-2025

Westamerica Bancorporation filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financial metrics are disclosed in the provided filing summary. Analysis is limited; full filing review recommended for materiality assessment.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 only.
• ·Core event under 8.01 not specified (NOT_DISCLOSED).
• ·No quantitative data (e.g., transaction value, financial metrics: NOT_DISCLOSED).

18-12-2025

Donegal Group Inc filed a Form 8-K on December 18, 2025, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details of the disclosure, core event, financial impacts, or exhibits are NOT_DISCLOSED in the provided summary. This is a multi-item voluntary filing compliant with Reg FD for material information.

• ·Items reported: 7.01 (Reg FD Disclosure) and 9.01 (Financial Statements/Exhibits)
• ·Multi-item voluntary disclosure; timing compliance NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, metrics) or event details provided

18-12-2025

CLOUDASTRUCTURE, INC. filed an 8-K on December 18, 2025, disclosing entry into a Material Definitive Agreement under Item 1.01 with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are provided in the summary. Analysis is limited to reported items; all other data is NOT_DISCLOSED.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into undisclosed Material Definitive Agreement.
• ·No quantitative data (e.g., transaction value, share count, financial metrics) disclosed.

18-12-2025

Community Bancorp /VT filed a Form 8-K on December 18, 2025, reporting under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financials, or exhibits are disclosed in the provided filing summary. Analysis is limited to filing metadata with all quantitative and event specifics NOT_DISCLOSED.

• ·Specific Items: 8.01 and 9.01 (multi-item filing)
• ·Event Type: General Filing, voluntary disclosure under catch-all Item 8.01
• ·No transaction values, financial metrics, or core event details provided

18-12-2025

DarkPulse, Inc. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided summary. Analysis limited to filing structure; core content of disclosure NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD) and 9.01 (exhibits).
• ·Timing and compliance details NOT_DISCLOSED; assumes standard 4-business-day window.
• ·No quantitative data (e.g., transaction value, shares, financial metrics) extracted: all NOT_DISCLOSED.

18-12-2025

Fusemachines Inc. filed a Form 8-K on December 18, 2025, reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosure content, transaction values, or financial impacts are provided in the filing summary. Analysis is limited to metadata, indicating a voluntary disclosure with unknown materiality.

• ·Single-item 8-K filing under Item 7.01 (Regulation FD Disclosure)
• ·Filed December 18, 2025; timing relative to event NOT_DISCLOSED
• ·Voluntary disclosure; sector not specified; no quantitative data extracted

18-12-2025

MSC INDUSTRIAL DIRECT CO INC filed an 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific content, events, financial metrics, or transaction details are disclosed in the provided filing summary. This appears to be a voluntary Reg FD disclosure with attached exhibits.

• ·Specific Items: 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing: Yes
• ·Voluntary disclosure: Yes (Reg FD typical)
• ·Quantitative data: All NOT_DISCLOSED (no values mentioned)

18-12-2025

Cars.com Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure facts with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director change event.
• ·Filed within SEC 8-K timeline (same day as event).
• ·No quantitative data (e.g., transaction values, shares, percentages) disclosed.

18-12-2025

GEE Group Inc. filed a Form 8-K on December 18, 2025, reporting Results of Operations and Financial Condition under Item 2.02 and attaching Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This is a standard financial results disclosure with limited details available.

• ·Items reported: 2.02 and 9.01 (multi-item filing)
• ·Core event: Disclosure of operations results and financial statements
• ·Quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

18-12-2025

Invesco Mortgage Capital Inc. filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, or financial metrics are explicitly stated in the provided filing summary. Analysis is constrained to metadata with all quantitative data as NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01 reported.
• ·Filed 2025-12-18; timing compliance and voluntary/mandatory status NOT_DISCLOSED.
• ·No facts on event nature, financial impact, or market expectations provided.

18-12-2025

Starfighters Space, Inc. filed an 8-K on December 18, 2025, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, or financials are provided in the filing summary. Analysis limited to metadata; core event and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Filed December 18, 2025; timing compliance NOT_DISCLOSED
• ·Voluntary disclosure under Reg FD; exhibits attached but content NOT_DISCLOSED

18-12-2025

Udemy, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323401), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, terms, or financial impact are disclosed in the provided summary. Analysis is limited to explicitly stated items; all transaction specifics are NOT_DISCLOSED.

• ·8-K reports Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into a Material Definitive Agreement; dollar value, share count, percentages, and financial metrics all NOT_DISCLOSED.
• ·No data on timing compliance, market reaction, related filings, or quantitative impacts; critical details missing.

18-12-2025

Vera Therapeutics, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the individual, position, appointment/resignation, reasons, or quantitative data provided in the summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates unspecified officer or director change.
• ·No names, positions (e.g., CEO/CFO), reasons, or timing details disclosed.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

18-12-2025

News Corp filed an 8-K on December 18, 2025, disclosing Other Events under Item 8.01 and Financial Statements/Exhibits under Item 9.01. No specific details on the core event, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (Other Events) and 9.01 (Exhibits).
• ·Core event and materiality NOT_DISCLOSED; voluntary disclosure under catch-all Item 8.01.
• ·No numerical values (transaction value, shares, financial metrics) or guidance changes mentioned.

18-12-2025

Global Net Lease, Inc. filed an 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, or financial metrics are disclosed in the provided summary. This is a multi-item voluntary filing with attached exhibits.

• ·Specific Items: 7.01 and 9.01; multi-item filing
• ·Regulation FD Disclosure (Item 7.01) suggests voluntary sharing of material information
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

18-12-2025

Primis Financial Corp. filed a Form 8-K on December 18, 2025, reporting an unspecified 'Other Event' under Item 8.01 and attaching exhibits under Item 9.01. No details on the event, transaction, or financial metrics are provided in the filing summary. Analysis is severely limited by lack of explicit content, rendering materiality and impact indeterminable.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: NOT_DISCLOSED (only 'Other Events' referenced).
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

18-12-2025

SeaStar Medical Holding Corp filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038276), reporting under Items 3.03 (Material Modifications to Rights of Security Holders) and 5.07 (Submission of Matters to a Vote of Security Holders). No specific details on the modifications, vote outcomes, or quantitative impacts are disclosed. This is a multi-item mandatory disclosure likely related to shareholder meeting results.

• ·Items reported: 3.03 and 5.07 (multi-item filing)
• ·Core event: Material modifications to security holders' rights and matters submitted to shareholder vote
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

Community West Bancshares filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, events, or financial metrics are provided in the filing summary. This is a multi-item, likely voluntary informational filing.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing with no core event or transaction details disclosed
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED

18-12-2025

California Resources Corp filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), along with other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing items and metadata; all quantitative data is NOT_DISCLOSED.

• ·Event involves merger/acquisition with completion reported under Item 2.01
• ·Material definitive agreement entered per Item 1.01
• ·Financial statements and exhibits included per Item 9.01; sector NOT_DISCLOSED

18-12-2025

Owens & Minor Inc/VA filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without disclosed material impacts.

• ·Item 5.02 signals officer change (departure, election, appointment, or compensatory arrangements), but key details NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional context in attachments.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) or specifics on leadership role, timing, or reasons extracted; all NOT_DISCLOSED.

18-12-2025

Aether Holdings, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001493152-25-028360) under Item 5.02 disclosing an officer change. No specifics on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the available summary. Analysis is severely limited by lack of filing details, resulting in neutral implications.

• ·Timely SEC 8-K filing under Item 5.02 for officer change.
• ·No details on key position (e.g., CEO/CFO), type (appointment/resignation), or reasons disclosed.
• ·Sector not specified; no quantitative data (shares, values, percentages) mentioned.

18-12-2025

Enova International, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01 and attaching exhibits under Item 9.01. Specific details of the agreement, transaction value, and financial impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing signaling a potentially significant event, but analysis is limited without full filing content.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED; timing compliance and strategic impact unknown.

18-12-2025

Fidelity National Financial, Inc. filed a Form 8-K on December 18, 2025, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, or exhibits are disclosed in the provided filing summary. Analysis is limited to filing structure, with all event specifics NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events, voluntary) and 9.01 (Exhibits); multi-item filing.
• ·Core event, financial impacts, and quantitative data: NOT_DISCLOSED.
• ·Timing compliance and materiality: NOT_DISCLOSED (event date and details absent).

18-12-2025

Accenture plc filed an 8-K on December 18, 2025, reporting under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Analysis is limited to filing structure and lacks substantive content for directional insights.

• ·Multi-item 8-K filing: Items 2.02 and 9.01
• ·Core event: Results of Operations and Financial Condition (details NOT_DISCLOSED)
• ·All quantitative data (revenue, EPS, etc.) NOT_DISCLOSED

18-12-2025

Rising Dragon Acquisition Corp. filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), submission of matters to a vote of security holders (Item 5.07), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on deal parties, structure, valuation, or quantitative metrics are disclosed in the filing summary. Analysis is limited to filing items with all key deal data marked as NOT_DISCLOSED.

• ·Item 1.01 indicates entry into a material definitive agreement, likely related to merger/acquisition.
• ·Item 5.07 reports submission of matters to shareholder vote.
• ·Items 8.01 and 9.01 cover other events and exhibits; sector NOT_DISCLOSED.

18-12-2025

FactSet Research Systems Inc filed an 8-K on December 18, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with exhibits likely attached.

• ·Specific Items: 2.02 and 9.01 reported in multi-item 8-K filing
• ·Core event: Results of Operations and Financial Condition
• ·Quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

18-12-2025

UniFirst Corp filed a Form 8-K on December 18, 2025, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing lacks specific details on votes, events, or exhibits in the provided summary. No quantitative data such as transaction values, share counts, or financial metrics disclosed.

• ·Multi-item 8-K: Items 5.07, 8.01, 9.01; likely mandatory for Item 5.07 (shareholder vote results)
• ·Core events and financial impacts NOT_DISCLOSED
• ·Routine disclosure typical for annual meeting votes; timing appears compliant (filed same day)

18-12-2025

INNO HOLDINGS INC. filed an 8-K on December 18, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the content of the disclosure or exhibits are provided in the filing summary. Analysis limited to disclosed items; core event and impacts NOT_DISCLOSED.

• ·8-K items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits) - multi-item voluntary filing.
• ·Timing: Filed on 2025-12-18; compliance with 4-business-day window cannot be assessed without event details.
• ·Quantitative data (transaction value, shares, financial metrics): all NOT_DISCLOSED.

18-12-2025

filed DEFM14A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001140361-25-046047 Size: 6 MB

• ·Filing Type: DEFM14A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001140361-25-046047 Size: 6 MB

18-12-2025

Pangaea Logistics Solutions Ltd. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). Specific details including officer names, positions affected, appointment/resignation status, or reasons are NOT_DISCLOSED. Analysis is limited by absence of filing content beyond item descriptions.

• ·Item 5.02 indicates officer or director change event
• ·Item 7.01 covers Regulation FD disclosure
• ·Item 9.01 lists financial statements and exhibits
• ·Filed timely on 2025-12-18 per SEC requirements; no quantitative data or specifics provided

18-12-2025

LightPath Technologies Inc filed an 8-K on December 18, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, proposals, or numerical data are disclosed in the filing summary. This is a standard mandatory disclosure for shareholder meeting results with limited details available.

• ·Single-item 8-K filing under Item 5.07.
• ·Core event: Disclosure of matters submitted to security holders vote; no transaction value or details provided (NOT_DISCLOSED).
• ·No financial metrics, share counts, or percentage changes mentioned (all NOT_DISCLOSED).

18-12-2025

Cocrystal Pharma, Inc. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure due to lack of content.

• ·Items reported: 7.01 (Reg FD Disclosure, voluntary) and 9.01 (Exhibits).
• ·Multi-item filing; timing compliance unknown (filed 2025-12-18).
• ·Core event and impacts NOT_DISCLOSED; quantitative data (transaction value, shares, financials) all NOT_DISCLOSED.

18-12-2025

Methode Electronics Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits, but specific details on position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing metadata; no substantive facts on leadership impact available.

• ·Item 5.02 disclosure signals officer change (departure, election, appointment, or compensatory arrangement), but key details NOT_DISCLOSED.
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Sector not specified; critical information on position affected, timing, and reasons missing, limiting analysis quality.

18-12-2025

Compass Diversified Holdings filed an 8-K on December 18, 2025, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard voluntary earnings-related disclosure.

• ·Specific Items: 2.02 and 9.01 (multi-item filing)
• ·Core event: Announcement of results of operations and financial condition
• ·Quantitative data: NOT_DISCLOSED (no numbers mentioned)

18-12-2025

Twin Vee PowerCats, Co. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. This appears to be a voluntary disclosure for Reg FD compliance with attached exhibits.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure under Reg FD; timing compliance NOT_DISCLOSED.
• ·No quantitative data (transaction value, shares, financial metrics) or core event details provided.

18-12-2025

Ligand Pharmaceuticals Inc. filed a Form 8-K on December 18, 2025, solely under Item 7.01 for Regulation FD Disclosure (Accession No. 0001193125-25-324830, 137 KB). No details on the core event, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a voluntary, single-item filing with limited analyzable content.

• ·Item 7.01: Regulation FD Disclosure only
• ·Single-item filing; voluntary disclosure
• ·Filed December 18, 2025; timing compliance NOT_DISCLOSED

18-12-2025

Athira Pharma, Inc. filed a Form 8-K on 2025-12-18 (AccNo: 0001193125-25-323692) reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, or financial metrics disclosed in the provided summary. Potential implications include strategic agreements and equity dilution, pending full filing review.

• ·Multi-item 8-K: Items 1.01, 3.02, 7.01, 8.01, 9.01.
• ·Core items suggest material agreement and unregistered equity sales.
• ·Filed on 2025-12-18; timing appears compliant (within 4 business days requirement, exact event timing NOT_DISCLOSED).

18-12-2025

PSQ Holdings, Inc. filed a Form 8-K on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided summary. Analysis is limited to filing metadata, with all quantitative data as NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Filed December 18, 2025; timing compliance NOT_DISCLOSED
• ·Voluntary/mandatory status unclear without event details

18-12-2025

Comerica Inc filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata, with all substantive content marked as NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01 (Other Events).
• ·Voluntary disclosure of unspecified event; timing compliance unknown.
• ·No quantitative data (e.g., transaction value, shares, financial metrics) or core event details provided.

18-12-2025

Incannex Healthcare Inc. filed an 8-K on December 18, 2025, under Item 8.01 (Other Events). No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core content absent.

• ·Single-item 8-K filing: Item 8.01 Other Events
• ·Filed 2025-12-18 (timing compliance NOT_DISCLOSED)
• ·No quantitative data (e.g., transaction value, shares: NOT_DISCLOSED); voluntary disclosure typical for 8.01

18-12-2025

filed DEFM14A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001193125-25-323606 Size: 3 MB

• ·Filing Type: DEFM14A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001193125-25-323606 Size: 3 MB

18-12-2025

Brand Engagement Network Inc. filed a Form 8-K on 2025-12-18 reporting Items 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 3.02 (Unregistered Equity Sales), 8.01 (Other Events), and 9.01 (Exhibits). No transaction details, values, or impacts are disclosed in the summary. Full filing review required for assessment.

• ·Multi-item mandatory 8-K filing covering agreement, financial obligation, equity sales, and other events.
• ·Quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED.
• ·Timing compliance and core event details: NOT_DISCLOSED.

18-12-2025

Artificial Intelligence Technology Solutions Inc. filed an 8-K on 2025-12-18 disclosing Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial data are provided in the filing summary. Analysis is limited to metadata with all core event information NOT_DISCLOSED.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure under Item 8.01 likely
• ·Timing and core event details NOT_DISCLOSED; no quantitative data extracted

18-12-2025

Performance Food Group Co filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with Regulation FD Disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reason, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 discloses officer change event, but key details (position, type, reason) NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure; content NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED

18-12-2025

BeOne Medicines Ltd. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer position, name, appointment/resignation status, or reasons are provided in the filing summary. Analysis is severely limited by absence of key facts, resulting in neutral investment implications.

• ·Item 5.02 disclosure confirms an officer or director change event.
• ·Filing date: December 18, 2025; AccNo: 0001651308-25-000151.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) or qualitative details (position, reason, internal/external) disclosed.

18-12-2025

CANNAPHARMARX, INC. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are provided in the filing summary. Analysis is limited to structural elements with all quantitative and event specifics NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; voluntary disclosure under Item 8.01
• ·No core event details, dollar values, or financial metrics disclosed

18-12-2025

Gray Media, Inc. filed an 8-K on December 18, 2025, under Item 8.01 Other Events. No details on the core event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata, indicating a voluntary disclosure of unspecified events.

• ·Single-item filing: Item 8.01 (Other Events)
• ·Voluntary disclosure; no mandatory trigger specified
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED)

18-12-2025

Kyverna Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123033), disclosing entry into a material definitive agreement (Item 1.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the summary. This multi-item filing signals a potentially significant development but lacks data for directional assessment.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01 reported.
• ·Core event: Entry into Material Definitive Agreement (mandatory disclosure).
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.

18-12-2025

Aspen Aerogels Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or disclosures are provided in the summary. Analysis is limited to filing structure due to lack of filing content.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

filed 8-K/A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001193125-25-323395 Size: 916 KB Item 9.01: Financial Statements and Exhibits

• ·Filing Type: 8-K/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001193125-25-323395 Size: 916 KB Item 9
• ·01: Financial Statements and Exhibits

18-12-2025

OneMain Holdings, Inc. filed a Form 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, values, or impacts are disclosed in the provided summary. This is a multi-item mandatory filing.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01
• ·Core event: Material definitive agreement creating financial obligation
• ·No quantitative data (e.g., transaction value: NOT_DISCLOSED)

18-12-2025

Avidity Biosciences, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), other events under Item 8.01, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 discloses officer change; specifics NOT_DISCLOSED
• ·Filed 2025-12-18 per SEC requirements
• ·No numerical values, names, or reasons stated

18-12-2025

Idaho Copper Corp filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are disclosed in the provided summary. Analysis limited to filing structure; core event content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (voluntary Other Events) and 9.01 (exhibits attached).
• ·No quantitative data (transaction value, shares, financial metrics) or event details extracted: all NOT_DISCLOSED.
• ·Compliance with 8-K timing cannot be assessed without event date; appears standard filing.

18-12-2025

ONE Gas, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core event undisclosed.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Filed 2025-12-18; timing compliance NOT_DISCLOSED
• ·No quantitative data, financial metrics, or event description provided

18-12-2025

VSEE Health, Inc. filed an 8-K on December 18, 2025, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, with exhibits under Item 9.01. No specific details on the amendments or changes are disclosed in the provided filing summary. Quantitative data and transaction details are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.03 (governance amendments/fiscal year change) and 9.01 (exhibits)
• ·Core event: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (details NOT_DISCLOSED)
• ·No numerical values, financial impacts, or strategic context provided

18-12-2025

Helix Energy Solutions Group Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation, reasons, or quantitative data are provided in the summary. Analysis is limited to filing metadata, indicating a routine SEC disclosure without directional implications.

• ·Item 5.02: Departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements
• ·Item 7.01: Regulation FD disclosure
• ·Item 9.01: Financial statements and exhibits filed

18-12-2025

Cambium Networks Corp filed an 8-K on December 18, 2025, reporting a notice of delisting or failure to satisfy continued listing rules (Item 3.01) and departure of directors or certain officers (Item 5.02), with exhibits under Item 9.01. This is a multi-item mandatory disclosure signaling significant listing and governance issues. No financial metrics, transaction values, or detailed event descriptions are provided in the filing summary.

• ·Items reported: 3.01 (Delisting notice), 5.02 (Director/officer departures), 9.01 (Exhibits)
• ·Multi-item filing; mandatory disclosures
• ·Filed same day as event date (2025-12-18), likely within 4-business-day requirement

18-12-2025

AIR T INC filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and creation of a direct financial obligation (Item 2.03). No specific details on parties, deal structure, valuation, or financial metrics are provided in the filing summary. Analysis is limited; all quantitative data is NOT_DISCLOSED.

• ·Completion of acquisition/disposition of assets reported under Item 2.01
• ·New material definitive agreement and financial obligation under Items 1.01 and 2.03
• ·Financial statements/exhibits referenced in Item 9.01, but content not detailed

18-12-2025

Darden Restaurants Inc filed an 8-K on December 18, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure with all key details marked as NOT_DISCLOSED.

• ·8-K items: 2.02 and 9.01 (multi-item filing)
• ·Core event: Financial results announcement
• ·No revenue, EPS, or other metrics provided (NOT_DISCLOSED)

18-12-2025

Avadel Pharmaceuticals PLC filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financials are provided in the summary. Analysis limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Likely voluntary disclosure (Reg FD and Other Events)
• ·Exhibits attached per Item 9.01; no quantitative data extracted (all NOT_DISCLOSED)

18-12-2025

Sagimet Biosciences Inc. filed an 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financial metrics are disclosed in the provided summary. Full filing review required for material assessment.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Likely voluntary disclosure (Reg FD and Other Events)
• ·Core event details, dollar values, and quantitative data: NOT_DISCLOSED

18-12-2025

Professional Diversity Network, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001437749-25-038280), reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or quantitative data are disclosed in the provided summary. Analysis limited to filing structure; full content review required for impact assessment.

• ·Multi-item mandatory 8-K filing: Items 1.01, 3.02, 9.01
• ·Core events involve material agreement and unregistered equity sales; all specifics (value, shares, terms) NOT_DISCLOSED
• ·No financial metrics, guidance changes, or related filings mentioned

18-12-2025

Teledyne Technologies Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements/Exhibits (Item 9.01). Specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED. Filing appears timely per SEC requirements.

• ·Item 5.02 signals officer change event, but key position (e.g., CEO/CFO), type (appointment/resignation), and reason (e.g., retirement/performance) are NOT_DISCLOSED.
• ·No board composition impact, governance details, succession signals, or quantitative metrics (transaction value, share count, percentages) disclosed.
• ·Routine SEC disclosure; no evidence of board meeting outcomes, dividends, M&A, or compliance issues.

18-12-2025

HBT Financial, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, or financial metrics are disclosed in the provided summary. Analysis is severely limited by absence of filing content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) - multi-item filing
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted: all NOT_DISCLOSED
• ·Voluntary/mandatory status, timing compliance, and core event details NOT_DISCLOSED

18-12-2025

Kalaris Therapeutics, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001193125-25-323706), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction details, values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, with all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing covering material agreement, equity sales, and other events.
• ·Core events: Material Definitive Agreement (Item 1.01) and Unregistered Sales of Equity Securities (Item 3.02).
• ·No dollar values, share counts, or financial impacts explicitly stated.

18-12-2025

Kodiak Sciences Inc. filed an 8-K on December 18, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Analysis is severely limited by absence of substantive content.

• ·Reported Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: NOT_DISCLOSED.
• ·Quantitative data (transaction value, shares, financial metrics): all NOT_DISCLOSED.

18-12-2025

Pyxis Oncology, Inc. filed an 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure) and 8.01 (Other Events). No specific details on the core event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is limited to filing structure due to lack of substantive content.

• ·Multi-item 8-K filing: Items 7.01 and 8.01.
• ·Regulation FD Disclosure (7.01) suggests voluntary update or press release.
• ·Other Events (8.01) indicates unspecified material event; all quantitative data NOT_DISCLOSED.

18-12-2025

MAXIMUS, INC. filed a Form 8-K on December 18, 2025, disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the filing summary. This represents a routine SEC disclosure with limited actionable information.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC requirements
• ·All specifics (position, appointment/resignation, reasons) NOT_DISCLOSED

18-12-2025

Third Coast Bancshares, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, financial metrics, or exhibits are disclosed in the filing summary. This is a multi-item filing with limited disclosed information.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing; voluntary disclosure under catch-all Item 8.01
• ·No quantitative data, event details, or financial impacts explicitly stated

18-12-2025

HOOKER FURNISHINGS Corp filed an 8-K on December 18, 2025, disclosing completion of an acquisition or disposition of assets under Item 2.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, structure, valuation, or terms are provided in the filing summary. All quantitative data including transaction value, share count, and financial metrics are NOT_DISCLOSED.

• ·Item 2.01 confirms completion of acquisition or disposition of assets
• ·Item 8.01 covers other events (details NOT_DISCLOSED)
• ·Item 9.01 includes financial statements and exhibits (contents NOT_DISCLOSED)

18-12-2025

FuelCell Energy Inc filed an 8-K on 2025-12-18 with Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific numerical data or details in the summary. Analysis limited to filing metadata; core content NOT_DISCLOSED.

• ·Specific Items: 2.02, 7.01, 9.01 (multi-item filing)
• ·Event: Financial results announcement via voluntary 8-K
• ·No quantitative data (revenue, EPS, etc.) or transaction details disclosed

18-12-2025

Karbon Capital Partners Corp. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. This is a general filing with limited information available for analysis.

• ·Specific Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing: Yes
• ·No quantitative data, transaction details, or financial metrics disclosed

18-12-2025

ASP Isotopes Inc. filed a Form 8-K on December 18, 2025, reporting under Item 7.01 Regulation FD Disclosure. No specific details of the disclosure, transaction, or financial impacts are stated in the provided filing summary. This appears to be a single-item, voluntary filing with limited available information.

• ·Item 7.01: Regulation FD Disclosure reported
• ·Filed 2025-12-18 (AccNo: 0001477932-25-009035)
• ·Sector not specified; quantitative data NOT_DISCLOSED

18-12-2025

BKV Corp filed a Form 8-K on December 18, 2025, disclosing under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Analysis is limited due to lack of substantive content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 reported.
• ·Item 8.01 indicates voluntary disclosure of an unspecified 'Other Event'.
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED.

18-12-2025

AMCON DISTRIBUTING CO filed an 8-K on December 18, 2025, reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, events, or financial data are disclosed in the filing summary. This is a multi-item, likely mandatory post-meeting disclosure with routine characteristics.

• ·Specific Items: 5.07, 8.01, 9.01 (multi-item filing).
• ·Core events: Shareholder votes and unspecified other events (details NOT_DISCLOSED).
• ·Quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Cognition Therapeutics Inc filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 1.02 (Termination of a Material Definitive Agreement). No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This mixed event signals contractual changes but lacks specifics for impact assessment.

• ·Multi-item 8-K filing: Items 1.01 and 1.02
• ·Core events: Entry into new MDA and termination of prior MDA
• ·All quantitative data (transaction value, share count, financial metrics): NOT_DISCLOSED

18-12-2025

Phibro Animal Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the summary. This is informational with no directional bias due to lack of explicit facts.

• ·Item 5.02: Disclosure of departure, election, or appointment of directors/officers.
• ·Item 7.01: Regulation FD disclosure included.
• ·No names, positions, reasons, or financial metrics disclosed.

18-12-2025

Newton Golf Company, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, shareholder vote results under Item 5.07, and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or vote outcomes are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics: NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of directors/officers, but key position, type (appointment/resignation), reason, and timing: NOT_DISCLOSED.
• ·Item 5.07 reports shareholder vote matters, but outcomes, proposals (dividends, approvals, etc.): NOT_DISCLOSED.
• ·No board composition changes, governance implications, succession details, or regulatory compliance issues explicitly stated.

18-12-2025

Red River Bancshares Inc filed an 8-K on December 18, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financials are provided in the filing summary. Analysis is severely limited by absence of substantive content.

• ·Specific Items: 8.01 and 9.01 (multi-item filing)
• ·Core event: NOT_DISCLOSED
• ·All quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED

18-12-2025

MPLX LP filed an 8-K on December 18, 2025, under Item 5.02 disclosing a change involving departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the filing summary. Analysis limited to header information only.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details NOT_DISCLOSED.
• ·No information on appointment/resignation, internal/external hire, reasons, or timing provided.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Marathon Petroleum Corp filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is limited to filing structure and triggered items, with all key change details NOT_DISCLOSED.

• ·Item 5.02 triggered for officer/director departure, election, appointment, or compensatory arrangements
• ·Filed timely on 2025-12-18 per SEC 8-K requirements (within 4 business days)
• ·Items 8.01 and 9.01 indicate additional events and exhibits, but contents NOT_DISCLOSED

18-12-2025

Core Natural Resources, Inc. filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific content, events, transactions, or financial data is disclosed in the provided summary. Analysis limited to filing structure; all quantitative details NOT_DISCLOSED.

• ·Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Regulation FD suggests voluntary disclosure of potentially material information.
• ·Exhibits mentioned but content and details NOT_DISCLOSED.

18-12-2025

NexMetals Mining Corp. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Analysis is limited to metadata, with all core event facts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 8.01 and 9.01 reported
• ·Filing date: 2025-12-18; timing compliance and event details NOT_DISCLOSED
• ·Voluntary disclosure likely (Item 8.01); no quantitative data or transaction specifics provided

18-12-2025

Myseum, Inc. filed an 8-K on December 18, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financials are provided in the filing summary. Analysis is limited to filing structure; core event details are NOT_DISCLOSED.

• ·Reported Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Timing and compliance: Filed on 2025-12-18; timeliness within 4 business days cannot be confirmed without market holiday data (NOT_DISCLOSED).
• ·Quantitative data: All metrics (transaction value, share count, percentages, financials) NOT_DISCLOSED.

18-12-2025

CarMax Inc filed an 8-K on 2025-12-18 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. Analysis is limited to filing structure; full document review required for substantive insights.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item 8-K filing; timing compliance and voluntary/mandatory status NOT_DISCLOSED
• ·Core event: Financial results announcement; all quantitative data (revenue, EPS, etc.) NOT_DISCLOSED

18-12-2025

Camp4 Therapeutics Corp filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all other data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01 reported.
• ·Core event: Entry into material definitive agreement (FACT), but terms NOT_DISCLOSED.
• ·Mandatory disclosure under SEC rules; timing compliance NOT_DISCLOSED.

18-12-2025

American Water Works Company, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or exhibits are provided in the filing summary. Insufficient information to assess materiality, financial impact, or market reaction.

• ·Multi-item 8-K filing: Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Voluntary disclosure under Item 8.01; core event details NOT_DISCLOSED
• ·No quantitative data (transaction value, shares, financial metrics) mentioned: all NOT_DISCLOSED

18-12-2025

TERAWULF INC. filed a Form 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with a 3 MB size, but specific event details, transaction values, or financial metrics are NOT_DISCLOSED in the provided summary. Analysis limited to filing metadata; core content unavailable.

• ·Multi-item 8-K: Items 7.01, 8.01, 9.01 reported
• ·Voluntary disclosure likely for Reg FD and Other Events; timing compliance unknown (must be within 4 business days)
• ·No quantitative data (e.g., transaction value, shares, financial metrics) or core event details disclosed

18-12-2025

Chimera Investment Corp filed an 8-K on December 18, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details of the disclosure, events, or financial data are NOT_DISCLOSED in the provided filing summary. This appears to be a voluntary disclosure with attached exhibits.

• ·Items reported: 7.01 (Regulation FD) and 9.01 (Exhibits); multi-item filing.
• ·Voluntary disclosure under Regulation FD; no mandatory event details provided.
• ·No quantitative data (transaction values, shares, financial metrics) extracted: all NOT_DISCLOSED.

18-12-2025

Golden Matrix Group, Inc. filed an 8-K on December 18, 2025, disclosing an event under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements) with exhibits under Item 9.01. Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. This is a routine SEC disclosure with no explicit facts on impact.

• ·Item 5.02 filing signals officer-related change or comp arrangement, but key details (position, internal/external, reason) NOT_DISCLOSED
• ·Filed timely (within 4 business days per SEC rules)
• ·No quantitative data (transaction value, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED
• ·Sector NOT_DISCLOSED; no board composition or governance specifics provided

18-12-2025

Phunware, Inc. filed an 8-K on December 18, 2025, disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders. No specific details on matters voted upon, outcomes, or numerical data are provided in the filing summary. This appears to be a standard mandatory post-shareholder meeting disclosure with limited disclosed information.

• ·Single-item 8-K filing under Item 5.07 (mandatory within 4 business days of shareholder vote)
• ·Core event: Reporting results of matters submitted to security holders vote; no vote specifics or outcomes disclosed
• ·No quantitative data (transaction value, shares, percentages, financial metrics) mentioned: all NOT_DISCLOSED

18-12-2025

Pulmatrix, Inc. filed a Form 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific event details, financial data, or transaction information are disclosed in the provided filing summary.

• ·Multi-item 8-K filing: Items 7.01, 8.01, and 9.01.
• ·Regulation FD disclosure and other events reported; exhibits attached.
• ·No quantitative data, core event, or financial impacts specified (all NOT_DISCLOSED).

18-12-2025

XWELL, Inc. filed an 8-K on December 18, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote results, proposals, or numerical data are disclosed in the provided filing summary. This is a routine mandatory disclosure for shareholder meeting outcomes.

• ·Single-item 8-K filing under Item 5.07 (mandatory for shareholder vote results)
• ·No transaction values, share counts, percentages, or financial metrics disclosed
• ·Filed on 2025-12-18; timing compliance and event details NOT_DISCLOSED

18-12-2025

Alight, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), alongside Regulation FD Disclosure (Item 7.01) and Financial Statements/Exhibits (Item 9.01). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited to disclosure of a leadership event without substantive content.

• ·Item 5.02 filing signals officer departure, election, appointment, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 7.01 includes Regulation FD Disclosure - content NOT_DISCLOSED
• ·Item 9.01 lists exhibits - details NOT_DISCLOSED; no financial metrics or transaction values extracted

18-12-2025

GlobalTech Corp filed an 8-K on December 18, 2025 (AccNo: 0001477932-25-009036), announcing completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Additional disclosures include Regulation FD information (Item 7.01) and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, or quantitative details are disclosed.

• ·Item 2.01 confirms completion of acquisition or asset disposition
• ·Item 3.02 discloses unregistered sales of equity securities
• ·Item 7.01 provides Regulation FD disclosure
• ·Item 9.01 includes financial statements and exhibits; details NOT_DISCLOSED

18-12-2025

Dragonfly Energy Holdings Corp. filed an 8-K on 2025-12-18 disclosing Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are provided in the summary. Analysis is limited; all quantitative data and event specifics are NOT_DISCLOSED.

• ·Multi-item 8-K filing covering governance changes (3.03, 5.03) and exhibits (9.01).
• ·Core event involves material modifications to security holder rights and corporate amendments; transaction value, share count, and financial metrics NOT_DISCLOSED.
• ·Filing timing and compliance cannot be assessed without full details; no revenue, balance sheet, or guidance impacts stated.

18-12-2025

Cardlytics, Inc. filed an 8-K on December 18, 2025, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Regulation FD Disclosure in Item 7.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to filing structure; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 discloses officer change event without specifics on key position (e.g., CEO/CFO) or nature (appointment/resignation)
• ·Item 7.01 includes Regulation FD Disclosure, potentially material non-public information
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

21Shares Solana ETF filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123314), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or quantitative impacts disclosed in the summary. Analysis limited to reported items; full filing review recommended.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (Item 1.01)
• ·Mandatory disclosure under SEC rules; timing compliance unknown without event date
• ·No transaction value, financial metrics, or other quantitative data disclosed

18-12-2025

Pebblebrook Hotel Trust filed an 8-K on December 18, 2025, under Item 7.01 for Regulation FD Disclosure. No details on the core event, transaction, or financial impacts are explicitly stated in the provided filing summary. This appears to be a voluntary disclosure to comply with Reg FD requirements.

• ·Single-item filing: Item 7.01 (Regulation FD Disclosure).
• ·Voluntary disclosure; timing compliance unknown as specific event details NOT_DISCLOSED.
• ·No quantitative data (transaction value, shares, financial metrics) disclosed in summary.

18-12-2025

Ategrity Specialty Insurance Co Holdings filed a Form 8-K on December 18, 2025, reporting under Item 7.01 Regulation FD Disclosure (Accession No. 0002040491-25-000020, 157 KB). This is a voluntary disclosure with no specific event details, transaction values, or quantitative data provided in the filing summary. Analysis is limited to metadata; core content not disclosed.

• ·Single-item filing: Item 7.01 (Regulation FD Disclosure)
• ·Voluntary disclosure; timing compliance unknown without event date
• ·No quantitative data (e.g., transaction value, financial metrics: NOT_DISCLOSED)
• ·Sector not specified; no material event details available

18-12-2025

Weyerhaeuser Co filed an 8-K on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to metadata, with all core event content NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 and 9.01 only.
• ·Regulation FD Disclosure (voluntary) with attached exhibits.
• ·No quantitative data (e.g., transaction values, financial metrics) extracted: all NOT_DISCLOSED.

18-12-2025

Trump Media & Technology Group Corp. filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or quantitative data are disclosed in the provided filing summary. Analysis is constrained to filing structure, indicating a potential voluntary material information release with attached exhibits.

• ·Multi-item 8-K: Items 7.01 and 9.01 reported.
• ·Item 7.01 suggests Regulation FD compliance for material non-public info.
• ·Item 9.01 indicates exhibits attached, content NOT_DISCLOSED.

18-12-2025

Sprinklr, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). Specific details on the officer position, nature of change (appointment/resignation), reasons, or quantitative data are NOT_DISCLOSED. Analysis limited to filing items; no facts on leadership impact or market reaction available.

• ·Item 5.02: Officer change event (details NOT_DISCLOSED)
• ·Item 7.01: Regulation FD disclosure (content NOT_DISCLOSED)
• ·Item 9.01: Financial statements and exhibits filed
• ·No quantitative data (shares, values, percentages: NOT_DISCLOSED)

18-12-2025

Axon Enterprise, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financial metrics are disclosed in the provided filing summary. This is a multi-item filing likely voluntary, with exhibits attached.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing
• ·Core event: NOT_DISCLOSED under Item 8.01

18-12-2025

DIRTT Environmental Solutions Ltd filed a Form 8-K on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific content, transaction details, or numerical data is disclosed in the provided summary. Analysis is limited to filing structure; all event specifics are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01, 8.01, 9.01
• ·Filed December 18, 2025 (timing relative to events NOT_DISCLOSED)
• ·Voluntary/mandatory status and core events NOT_DISCLOSED

18-12-2025

Integrated Wellness Acquisition Corp, a SPAC, filed an 8-K on December 18, 2025, announcing a Merger/Acquisition via Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific deal details such as parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing metadata, with all quantitative and qualitative deal terms NOT_DISCLOSED.

• ·8-K filing discloses merger/acquisition event under Items 7.01 and 9.01.
• ·AccNo: 0001104659-25-122565, filed 2025-12-18, file size 244 KB.
• ·Sector NOT_DISCLOSED; no parties, valuation, or structure specified.

18-12-2025

Werewolf Therapeutics, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction value, or financial metrics are disclosed in the provided filing summary. Analysis limited to disclosed items; core event content NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) - multi-item filing.
• ·Voluntary disclosure under 8.01; timing compliance NOT_DISCLOSED.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): all NOT_DISCLOSED.

18-12-2025

Greenwich LifeSciences, Inc. filed an 8-K on December 18, 2025, reporting Item 5.07 on Submission of Matters to a Vote of Security Holders. This is a single-item mandatory disclosure of shareholder meeting results, with no specific vote details, outcomes, or quantitative data provided in the filing summary. The event appears informational without disclosed financial or strategic impacts.

• ·Specific Item 5.07 reported; single-item filing.
• ·Mandatory disclosure under SEC 8-K rules for shareholder votes.
• ·No transaction values, share counts, or financial metrics disclosed.

18-12-2025

Ocular Therapeutix, Inc. filed an 8-K on December 18, 2025, under Item 8.01 Other Events. No specific details on the event, transaction value, financial impact, or other quantitative data are disclosed in the provided filing summary. Analysis is limited to the reported item due to lack of filing content.

• ·8-K filing reporting Item 8.01: Other Events
• ·Filed on 2025-12-18 (AccNo: 0001104659-25-122564)
• ·Sector not specified; no numerical data or event details extracted

18-12-2025

Amaze Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, or reasons are provided in the filing summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates a leadership change event (officer departure, election, or appointment), but key details like position (e.g., CEO/CFO) and nature (resignation/appointment) are NOT_DISCLOSED.
• ·Includes Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01), suggesting potential additional material information.
• ·Filed timely per SEC 8-K requirements; sector NOT_DISCLOSED.

18-12-2025

Zynex Inc filed an 8-K on December 18, 2025, disclosing bankruptcy or receivership (Item 1.03), entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and notice of delisting (Item 3.01). No specific details, dollar values, or financial metrics are provided in the filing summary. This represents a multi-item filing signaling severe financial distress.

• ·Multi-item 8-K filing: Items 1.01, 1.03, 2.03, 3.01, 9.01.
• ·Core event: Bankruptcy or receivership; material agreement and financial obligation creation.
• ·Delisting notice indicates failure to meet listing standards.

18-12-2025

Lockheed Martin filed an 8-K on December 18, 2025, solely under Item 8.01 Other Events. No details on the event, transaction, financials, or impacts are disclosed in the provided summary. This limits analysis to procedural aspects only.

• ·Single-item filing: Item 8.01 Other Events
• ·Voluntary disclosure; no mandatory trigger specified
• ·No quantitative data or event description provided (all NOT_DISCLOSED)

18-12-2025

WhiteFiber, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123321), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). Specific details on the agreement, transaction value, financial impacts, or strategic importance are NOT_DISCLOSED. Analysis is limited to filing structure due to lack of substantive content provided.

• ·Multi-item 8-K filing: Items 1.01, 7.01, 9.01
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); filing timing compliance unknown

18-12-2025

Data Storage Corp filed a Form 8-K on December 18, 2025, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, or exhibits are disclosed in the provided filing summary. This is a multi-item filing with limited visible content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Filing date: 2025-12-18, AccNo: 0001731122-25-001689
• ·No quantitative data, event details, or financial metrics extracted (all NOT_DISCLOSED)

18-12-2025

Interactive Strength, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data provided in the summary. Analysis limited to item descriptions; core event and impacts NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 2.03, 3.02, 8.01 reported.
• ·Timing: Filed 2025-12-18; compliance with 4-business-day window NOT_DISCLOSED.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

CION Investment Corp filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation size, or impacts are NOT_DISCLOSED. Analysis is limited to item descriptions with no quantitative data provided.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
• ·Core event: Entry into material agreement and new financial obligation
• ·No transaction value, financial metrics, or strategic details disclosed

18-12-2025

Picard Medical, Inc. filed an 8-K on December 18, 2025, disclosing under Item 7.01 (Regulation FD) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are provided in the summary. Critical filing content is missing, limiting analysis to form structure only.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD disclosure) and 9.01 (exhibits).
• ·No core event, dollar values, or quantitative data disclosed.
• ·Timing compliance and materiality cannot be assessed without full filing content.

18-12-2025

Kindly MD, Inc. filed a Form 8-K on December 18, 2025, disclosing Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financial metrics are provided in the filing summary. Analysis is limited to item disclosures; core events and impacts are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 5.07, 7.01, 8.01, 9.01.
• ·Timing compliance unknown; filed within standard 4 business days window presumed but unconfirmed.
• ·No quantitative data (transaction values, shares, financial metrics) disclosed.

18-12-2025

Energy Services of America CORP filed a Form 8-K on December 18, 2025, disclosing an event under Item 8.01 (Other Events). No details on the core event, financial impacts, or quantitative metrics are provided in the filing summary. Analysis limited to metadata; all specifics NOT_DISCLOSED.

• ·Single-item 8-K filing under Item 8.01: Other Events
• ·Filed 2025-12-18 (AccNo: 0001104659-25-122338); timing compliance unknown
• ·No transaction values, financial metrics, or strategic details extracted (all NOT_DISCLOSED)

18-12-2025

Treace Medical Concepts, Inc. filed a multi-item 8-K on December 18, 2025 (AccNo: 0001193125-25-323802), reporting entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to security holders' rights (Item 3.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific transaction values, financial metrics, or details are disclosed in the provided summary. This indicates significant corporate developments, but analysis is limited without full filing content.

• ·Multi-item mandatory 8-K filing covering agreements, financial obligations, and security holder rights changes
• ·Filed on event date (2025-12-18), likely within 4-business-day requirement
• ·All quantitative data (transaction value, share count, percentages) NOT_DISCLOSED

18-12-2025

SR Bancorp, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event or contents of exhibits are disclosed in the provided filing summary. Analysis is limited to filing metadata with all event specifics and quantitative data marked as NOT_DISCLOSED.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item voluntary 8-K filing; timing compliance NOT_DISCLOSED
• ·No core event details, transaction values, financial metrics, or quantitative data disclosed

18-12-2025

eHealth, Inc. filed a multi-item Form 8-K on December 18, 2025, reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, or financial impacts are disclosed in the provided filing summary. Analysis is limited to item descriptions, indicating potential governance changes and voluntary information disclosure.

• ·Multi-item 8-K filing: Items 5.03, 7.01, 9.01
• ·Item 5.03 suggests amendments to governing documents or fiscal year change (mandatory if material)
• ·Item 7.01 indicates Regulation FD disclosure (typically voluntary)
• ·Item 9.01 lists financial statements/exhibits; content NOT_DISCLOSED

18-12-2025

Ovid Therapeutics Inc. filed an 8-K on December 18, 2025, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, or exhibits are disclosed in the provided summary. Analysis is severely limited by absence of filing content.

• ·Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event, financials, and quantitative data: NOT_DISCLOSED.
• ·Timing, materiality, and impacts: NOT_DISCLOSED due to lack of filing details.

18-12-2025

Greenpro Capital Corp. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. No specific transaction details, values, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments, but analysis is limited without full filing content.

• ·Multi-item 8-K: Items 1.01, 3.02, 9.01 reported.
• ·Core events involve material agreement and unregistered equity sales; all quantitative data NOT_DISCLOSED.
• ·Filed same day as event; compliance with 4-business-day window presumed but unverified.

18-12-2025

Liberty Global Ltd. filed an 8-K on December 18, 2025, reporting Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, transaction values, or financial metrics are disclosed in the provided filing summary. Analysis is limited to filing structure; content review required for materiality assessment.

• ·Multi-item 8-K filing: Items 7.01 (voluntary Reg FD) and 9.01 (exhibits).
• ·No core event, dollar values, or quantitative data explicitly stated.
• ·Timing compliance and strategic context NOT_DISCLOSED.

18-12-2025

PureCycle Technologies, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position, individual, reason, or quantitative data are provided in the summary. Item 9.01 references financial statements and exhibits, but content is NOT_DISCLOSED.

• ·Item 5.02 filing indicates unspecified officer change, appointment, or compensatory arrangement.
• ·No names, positions (e.g., CEO/CFO), reasons (e.g., resignation/retirement), or timing details disclosed.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Avantor, Inc. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of certain officers; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD Disclosure; content NOT_DISCLOSED
• ·Item 9.01: Financial Statements and Exhibits; details NOT_DISCLOSED

18-12-2025

Cartesian Growth Corp III filed a Form 8-K on December 18, 2025, reporting Items 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, or quantitative data are disclosed in the provided summary. Analysis is limited to filing structure; core event and impacts are NOT_DISCLOSED.

• ·Multi-item mandatory 8-K filing (Items 1.01, 3.02, 7.01, 9.01); filing date aligns with event but intra-day timing NOT_DISCLOSED.
• ·Core event involves material definitive agreement and unregistered equity sales; strategic importance and financial impacts NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.

18-12-2025

Cintas Corp filed an 8-K on 2025-12-18 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. This is a standard multi-item filing for earnings-related disclosures.

• ·Items reported: 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; timing compliance NOT_DISCLOSED
• ·No revenue, earnings, transaction values, or other quantitative data disclosed

18-12-2025

DiaMedica Therapeutics Inc. filed an 8-K on December 18, 2025, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, or financials are disclosed in the provided filing summary. Analysis is limited to filing structure; core content NOT_DISCLOSED.

• ·Multi-item 8-K filing (7.01, 8.01, 9.01); voluntary disclosures typical for these items.
• ·No quantitative data (transaction value, shares, financial metrics) extracted: all NOT_DISCLOSED.
• ·Timing compliance and event details NOT_DISCLOSED; no material event facts available.

18-12-2025

Beyond Meat, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, covering departures, elections, appointments, or compensatory arrangements of certain officers. No specific details on the affected position, individual, reason, or terms are provided in the filing summary. This is a routine SEC disclosure with no quantified financial or strategic impacts stated.

• ·Item 5.02: Officer change event (departure, appointment, or compensatory arrangements)
• ·Filed: 2025-12-18, AccNo: 0001655210-25-000220
• ·No names, positions, reasons, or numerical data disclosed

18-12-2025

filed 8-K/A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001801661-25-000085 Size: 262 KB Item 4.01: Changes in Registrant's Certifying Accountant Item 9.01: Financial Statemen...

• ·Filing Type: 8-K/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001801661-25-000085 Size: 262 KB Item 4
• ·01: Changes in Registrant's Certifying Accountant Item 9

18-12-2025

Nuvve Holding Corp. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details, events, or quantitative data from the disclosure content are provided in the filing summary. This appears to be a voluntary multi-item filing with limited transparency on material events.

• ·Multi-item 8-K: Items 7.01 (Reg FD, voluntary) and 9.01 (exhibits)
• ·No core event, transaction details, or financial metrics disclosed
• ·Timing and compliance details NOT_DISCLOSED

18-12-2025

Electromed, Inc. filed an 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). Specific transaction details, values, and impacts are NOT_DISCLOSED in the provided summary. This is a multi-item mandatory filing likely compliant with 4-business-day SEC timing.

• ·Multi-item 8-K filing: Items 1.01 (Material Definitive Agreement), 2.03 (Financial Obligation), 9.01 (Exhibits)
• ·Core event involves a material agreement creating financial obligations; dollar value, share count, and metrics NOT_DISCLOSED
• ·Voluntary/mandatory: Mandatory disclosure for material events; no quantitative financial impacts specified

18-12-2025

CF Bankshares Inc. filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, or financial impacts are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, and financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (Other Events, voluntary) and 9.01 (Exhibits)
• ·Timing compliance and event details NOT_DISCLOSED
• ·No revenue, earnings, balance sheet effects, or guidance changes specified

18-12-2025

Howard Hughes Holdings Inc. filed a Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the agreement, transaction values, or impacts are disclosed in the provided summary. This is a multi-item filing likely mandatory for Items 1.01 and 3.02.

• ·Multi-item 8-K: Items 1.01 (material agreement), 3.02 (unregistered equity sales), 7.01 (Reg FD), 9.01 (exhibits)
• ·Core events involve material agreement and equity sales; quantitative details NOT_DISCLOSED
• ·Filing within same day of event date; compliance with 4-business-day window presumed but timing precision unknown

18-12-2025

Gain Therapeutics, Inc. filed a Form 8-K on December 18, 2025, under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is constrained by lack of explicit content, limiting materiality assessment.

• ·Single-item filing: Item 8.01 Other Events
• ·Likely voluntary disclosure; timing compliance cannot be assessed without event date
• ·No quantitative data (e.g., transaction value, share count, financial metrics) disclosed

18-12-2025

Skkynet Cloud Systems, Inc. filed a Form 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement under Item 1.01, with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Full filing review required for substantive analysis.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; core event is entry into a material agreement
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

Gulf Resources, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis limited to metadata; core event and materiality NOT_DISCLOSED.

• ·Item 8.01: Other Events (single-item filing)
• ·Voluntary disclosure; timing compliance unknown
• ·No quantitative data (transaction value, shares, financial metrics: NOT_DISCLOSED)

18-12-2025

DIH HOLDING US, INC. filed a Form 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary.

• ·Item 5.02 indicates officer change or compensatory arrangements; specifics NOT_DISCLOSED
• ·Filed timely per SEC requirements on 2025-12-18 (AccNo: 0001493152-25-028295)
• ·Sector NOT_DISCLOSED; no quantitative data (e.g., transaction values, share counts) extracted

18-12-2025

Unitil Corp filed a Form 8-K on December 18, 2025, under Items 7.01 (Regulation FD Disclosure) and 8.01 (Other Events). No specific details on events, transactions, or financial impacts are disclosed in the provided summary. Analysis limited to filing metadata; core content unavailable.

• ·Multi-item 8-K filing: Items 7.01 and 8.01.
• ·Voluntary disclosures typical for these items.
• ·No quantitative data or event specifics provided.

18-12-2025

Pulse Biosciences, Inc. filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction value, or financial impacts are disclosed in the provided filing summary. Analysis is severely limited by absence of substantive content.

• ·Items reported: 8.01 (Other Events, voluntary) and 9.01 (Exhibits).
• ·Multi-item filing; timing compliance NOT_DISCLOSED.
• ·Core event details, quantitative data (e.g., transaction value, share count), and financial impacts all NOT_DISCLOSED.

18-12-2025

Otter Tail Corp filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02, with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on position, appointment/resignation, reason, or quantitative data are provided in the summary. Analysis limited to filing structure; all other facts NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of officers/directors; specifics NOT_DISCLOSED
• ·Item 7.01: Regulation FD disclosure, content NOT_DISCLOSED
• ·Item 9.01: Financial statements/exhibits filed, details NOT_DISCLOSED

18-12-2025

ENB Financial Corp filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), officer/director changes or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, or quantitative impacts are provided in the summary. Analysis is limited due to lack of filing content.

• ·Multi-item 8-K filing covering material agreement, financial obligation, management changes, and Reg FD disclosure.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.
• ·Timing and compliance with 4-business-day requirement cannot be assessed without full filing.

18-12-2025

Femasys Inc. filed an 8-K on December 18, 2025, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the event, transaction, or financials are provided in the filing summary. Analysis is limited due to lack of substantive content.

• ·Multi-item 8-K filing: Items 8.01 (Other Events, voluntary) and 9.01 (Exhibits).
• ·No core event, dollar values, financial metrics, or quantitative data disclosed (all NOT_DISCLOSED).
• ·Timing compliance and materiality cannot be assessed without event details.

18-12-2025

FG Nexus Inc. filed an 8-K on December 18, 2025, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on votes, outcomes, or matters submitted are provided in the filing summary. This appears to be a routine mandatory disclosure for shareholder meeting results.

• ·Single-item 8-K filing under Item 5.07 (mandatory for certain shareholder votes).
• ·No quantitative data (e.g., transaction values, share counts, percentages) disclosed.
• ·Timing compliance and event details not specified in summary.

18-12-2025

Innovative Solutions & Support Inc. filed an 8-K on December 18, 2025, reporting financial results under Item 2.02 (Results of Operations and Financial Condition) with exhibits under Item 9.01. No specific financial metrics, transaction values, or outcomes are disclosed in the provided summary. This is a routine earnings-related disclosure with limited details available for analysis.

• ·Items reported: 2.02 and 9.01 (multi-item filing)
• ·Core event: Financial results announcement
• ·All quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

18-12-2025

Syra Health Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis is limited to disclosure of the event without substantive content.

• ·Officer change event reported under SEC Item 5.02
• ·Additional Items 8.01 and 9.01 filed, details NOT_DISCLOSED
• ·No names, positions, reasons, or numerical data (e.g., shares, values) specified

18-12-2025

LEE ENTERPRISES, Inc filed a Form 8-K on December 18, 2025, reporting solely under Item 8.01 (Other Events). No details on the core event, financial impacts, or quantitative metrics are disclosed in the provided filing summary. Analysis is constrained to metadata, indicating a single-item voluntary disclosure.

• ·Specific Item: 8.01 (Other Events); single-item filing.
• ·Filing date: 2025-12-18; compliance with 4-business-day window cannot be assessed without event trigger date.
• ·Voluntary disclosure under Item 8.01, as no mandatory items (e.g., 1.01, 2.01) reported.

18-12-2025

Sonim Technologies Inc. filed an 8-K on 2025-12-18 disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), material modifications to security holder rights (Item 3.03), other events (Item 8.01), and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, transaction value, share counts, or financial metrics are disclosed in the provided summary. This indicates a completed significant corporate transaction with potential equity and obligation implications.

• ·Multiple 8-K items triggered signaling completed M&A and related events
• ·Quantitative data including transaction value, share counts, percentages, and financial metrics: NOT_DISCLOSED
• ·Exhibits (Item 9.01) likely contain agreement details, but not summarized here

18-12-2025

LKQ Corp filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), plus other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, dollar values, or financial metrics are disclosed in the provided summary. Analysis is limited to item descriptions, indicating a potentially significant corporate action.

• ·Multi-item mandatory 8-K filing covering material agreement and new financial obligations.
• ·Filed same day as event date, likely within 4-business-day requirement.
• ·Exhibits filed but contents not specified; all quantitative data NOT_DISCLOSED.

18-12-2025

Constellation Acquisition Corp I filed an 8-K on December 18, 2025 (AccNo: 0001213900-25-123069), reporting a Merger/Acquisition event under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific deal structure, parties, valuation, or quantitative details are disclosed in the provided filing summary. Analysis is limited to filing metadata; all key M&A elements are NOT_DISCLOSED.

• ·Event classified as Merger/Acquisition by filer.
• ·Items 7.01 and 9.01 suggest press release or exhibits with material non-public information.
• ·Sector NOT_DISCLOSED; no numerical data (e.g., transaction value, shares, percentages) extracted.

18-12-2025

BankFinancial CORP filed an 8-K on December 18, 2025, reporting only Item 5.07 on Submission of Matters to a Vote of Security Holders. No details on specific proposals, vote outcomes, or numerical data are disclosed in the provided filing summary. This is a standard, mandatory disclosure likely related to a shareholder meeting.

• ·Single-item 8-K: Item 5.07 only
• ·Core event: Shareholder vote submission (details NOT_DISCLOSED)
• ·No quantitative data (transaction value, shares, percentages: NOT_DISCLOSED)

18-12-2025

FIRST FINANCIAL CORP /IN/ filed an 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction, or financial data are disclosed in the filing summary. Analysis is limited due to absence of substantive content.

• ·Multi-item 8-K filing: Items 8.01 and 9.01 only.
• ·Core event under Item 8.01 not described; exhibits referenced but unspecified.
• ·All quantitative data (transaction value, shares, metrics) NOT_DISCLOSED.

18-12-2025

Cosmos Health Inc. filed an 8-K on December 18, 2025, under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule) and 9.01 (Financial Statements and Exhibits), indicating a delisting event from US markets. No specific details on reasons, values, or impacts are disclosed in the provided summary. This is a material negative event signaling listing non-compliance.

• ·Items 3.01 and 9.01 reported in multi-item 8-K filing.
• ·Core event: Notice of delisting or failure to satisfy listing standards.
• ·No quantitative data (transaction value, shares, financial metrics) disclosed.

18-12-2025

Mills Music Trust filed a Form 8-K on December 18, 2025, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction value, financial impacts, or quantitative data are disclosed in the provided filing summary. Analysis is severely limited by absence of substantive content.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Voluntary disclosure typical for Item 8.01; timing compliance NOT_DISCLOSED.
• ·Core event, dollar values, financial metrics, and strategic details all NOT_DISCLOSED.

18-12-2025

Berry Corp (BRY) 8-K filing on 2025-12-18 reports completion of an acquisition or disposition of assets (Item 2.01), termination of a prior material definitive agreement (Item 1.02), delisting notice (Item 3.01), change in control (Item 5.01), and related governance changes. No details on parties, deal structure, valuation, or consideration disclosed. All quantitative metrics (transaction value, shares, percentages) are NOT_DISCLOSED.

• ·Event signals deal completion with change in control and delisting, likely indicating acquisition of BRY or major asset sale.
• ·Governance shifts include director/officer changes (Item 5.02) and amendments to articles/bylaws (Item 5.03).
• ·Critical data missing: acquirer/target identities, value, consideration type (cash/stock), synergies, EPS impact.

18-12-2025

Webstar Technology Group Inc. disclosed the completion of an acquisition or disposition of assets via Item 2.01 in an 8-K filing on December 18, 2025 (AccNo: 0001493152-25-028379). No details on parties involved, deal structure, valuation, or strategic rationale are provided in the filing summary. Analysis is severely limited by absence of key quantitative and qualitative data.

• ·Event: Completion of Acquisition or Disposition of Assets (Item 2.01).
• ·Filing date: 2025-12-18; Sector: NOT_DISCLOSED.
• ·All transaction specifics (value, parties, consideration): NOT_DISCLOSED.

18-12-2025

Bitcoin Depot Inc. filed a Form 8-K on December 18, 2025, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses shareholder meeting voting results and attaches exhibits. No specific vote details, financial metrics, or transaction values are provided in the summary.

• ·Specific Items: 5.07 and 9.01 (multi-item filing)
• ·Core event: Shareholder vote results (mandatory disclosure)
• ·All quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Greenidge Generation Holdings Inc. filed an 8-K on December 18, 2025, under Item 8.01 Other Events (AccNo: 0001628280-25-057939, Size: 190 KB). No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is limited to metadata; core event content is NOT_DISCLOSED.

• ·Item 8.01: Other Events reported
• ·Filing date: 2025-12-18
• ·Single-item filing (only 8.01 specified)

18-12-2025

Two Hands Corp filed an 8-K on December 18, 2025, reporting Item 3.02: Unregistered Sales of Equity Securities. No details on transaction value, share count, purchasers, or terms are disclosed in the provided filing summary. This flags potential dilution but lacks data for materiality assessment.

• ·Single-item 8-K filing under Item 3.02 (mandatory for qualifying unregistered equity sales)
• ·No quantitative data (value, shares: NOT_DISCLOSED)
• ·Sector not specified; no timing or related filings mentioned

18-12-2025

Parsons Corp filed an 8-K on December 18, 2025, disclosing Item 5.02 regarding departure of directors/officers, elections, appointments, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the summary. Analysis is severely limited by absence of filing content.

• ·Item 5.02 disclosure on officer/director changes or compensatory arrangements
• ·Event and filing date: December 18, 2025
• ·All specifics (positions, appointment/resignation, reasons, financials): NOT_DISCLOSED

18-12-2025

Arena Group Holdings, Inc. filed an 8-K on December 18, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item, mandatory disclosure with no specific vote details, outcomes, or numerical data provided in the summary. Routine filing likely following a shareholder meeting.

• ·Item 5.07 only: Submission of Matters to a Vote of Security Holders
• ·Single-item 8-K filing
• ·Mandatory disclosure; timing compliance NOT_DISCLOSED (meeting date absent)

18-12-2025

UNITY BANCORP INC /NJ/ filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, individual name, appointment/resignation status, reason, or quantitative data such as transaction values, share counts, or financial metrics are provided in the filing summary. This appears to be a routine disclosure with limited information available for analysis.

• ·Item 5.02: Officer change event disclosed, but key details (position, name, reason) NOT_DISCLOSED
• ·Filed on 2025-12-18; AccNo: 0000920427-25-000085
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·Sector not specified

18-12-2025

Reliance Global Group, Inc. filed a Form 8-K on December 18, 2025, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No additional details, numerical values, or transaction specifics are provided in the filing summary.

• ·Items reported: 3.01 (delisting notice) and 9.01 (financials/exhibits)
• ·Multi-item mandatory 8-K filing on delisting event
• ·Core event: Notice of delisting or listing rule failure; all other metrics (value, impact, financials) NOT_DISCLOSED

18-12-2025

VivoSim Labs, Inc. filed an 8-K on December 18, 2025, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). No specific details on vote outcomes, exhibits, or quantitative data are disclosed in the provided filing summary. This appears to be a routine disclosure of shareholder meeting results with attached exhibits.

• ·8-K items: 5.07 (shareholder vote) and 9.01 (exhibits)
• ·No transaction values, share counts, or financial metrics disclosed
• ·Sector not specified; critical details like vote results missing

18-12-2025

Inspirato Inc filed an 8-K on December 18, 2025, reporting entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), with exhibits under Item 9.01. No specific details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This represents a multi-item filing with mixed implications pending further details.

• ·Multi-item 8-K: Items 1.01 (entry), 1.02 (termination), 9.01 (exhibits)
• ·Core event: Entry into and termination of material definitive agreements; all quantitative data (value, shares, metrics) NOT_DISCLOSED
• ·Compliance appears standard; no timing violations evident from date match, but details absent

18-12-2025

Arcus Biosciences, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001724521-25-000122), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the transaction nature, parties, terms, or dollar value are disclosed in the provided information. This multi-item filing signals a potentially significant corporate development with financial implications.

• ·Multi-item 8-K: Items 1.01 (Material Definitive Agreement) and 2.03 (Financial Obligation/Off-Balance Sheet Arrangement)
• ·Core event: Entry into material agreement creating financial obligation; all quantitative data NOT_DISCLOSED
• ·Timing and compliance details NOT_DISCLOSED; sector not specified

18-12-2025

VerifyMe, Inc. filed an 8-K on December 18, 2025 (AccNo: 0001214659-25-018223), reporting under Item 3.01 a notice of delisting or failure to satisfy continued US exchange listing rules. This is a mandatory disclosure of a material negative event with no additional details on reasons, financial impacts, or transaction values provided. Delisting typically impairs liquidity and investor access.

• ·Single-item 8-K filing under Item 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule)
• ·Event dated December 18, 2025; filed same day, likely within 4-business-day requirement
• ·No quantitative data (e.g., transaction value, share count: NOT_DISCLOSED); sector not specified

18-12-2025

Affirm Holdings, Inc. filed an 8-K on December 18, 2025, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific vote details, outcomes, or numerical data disclosed in filing summary. This is a routine informational disclosure with no evident material financial or strategic impact.

• ·Single-item 8-K filing under Item 5.07 (mandatory for shareholder vote results).
• ·Core event: Disclosure of security holder vote matters; no transaction value, share counts, or financial metrics mentioned (NOT_DISCLOSED).
• ·No guidance changes, financial impacts, or market-moving details provided.

18-12-2025

Corbus Pharmaceuticals Holdings, Inc. filed an 8-K on December 18, 2025, disclosing an Item 5.02 event related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements, but no specific details on positions, reasons, or individuals are provided in the summary. Quantitative data such as transaction values, share counts, or percentages are NOT_DISCLOSED. Analysis is limited by lack of filing content, resulting in neutral implications.

• ·Item 5.02 filing indicates officer/director change or compensatory arrangement, but key details (position, appointment/resignation, reason) NOT_DISCLOSED.
• ·Filed within SEC 8-K timeline (within 4 business days), compliant with disclosure requirements.
• ·No board meeting outcomes, financial metrics, or governance impacts specified.

18-12-2025

ENVIRI Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 indicates officer-related change, but key position (e.g., CEO, CFO) is NOT_DISCLOSED
• ·No reasons, timing, or succession details stated
• ·Item 9.01 references exhibits, but contents/content NOT_DISCLOSED; sector not specified

18-12-2025

InMed Pharmaceuticals Inc. filed a multi-item 8-K on December 18, 2025, reporting shareholder vote results (Item 5.07), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific details on vote outcomes, disclosure content, or quantitative data are provided in the filing summary. This appears to be an informational filing with neutral implications absent further details.

• ·Multi-item 8-K: Items 5.07 (mandatory shareholder votes), 7.01 (voluntary Reg FD), 9.01 (exhibits)
• ·No transaction values, share counts, or financial metrics disclosed (all NOT_DISCLOSED)
• ·Timing compliance and core event details unavailable from summary

18-12-2025

Burke & Herbert Financial Services Corp. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into Material Definitive Agreement), 5.03 (Amendments to Articles of Incorporation or Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing indicates a significant event but lacks specific details on the agreement, amendments, or disclosures in the provided summary. Quantitative data such as transaction value, share count, or financial metrics are NOT_DISCLOSED.

• ·Multi-item 8-K: Items 1.01, 5.03, 7.01, 9.01 reported
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Timing: Filed on event date 2025-12-18; compliance with 4-business-day window cannot be confirmed without full filing

18-12-2025

Indivior PLC filed an 8-K on December 18, 2025, under Item 5.02 disclosing a departure, election, appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit information.

• ·Item 5.02 filing indicates officer/director change event
• ·Filed timely: 2025-12-18 (AccNo: 0001625297-25-000076)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Korro Bio, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with exhibits under Item 9.01. No specific details on position affected, appointment/resignation, reasons, or quantitative data are stated in the provided filing summary. All key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 indicates officer-related change (departure, appointment, or compensatory arrangement), but specifics NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) mentioned: all NOT_DISCLOSED
• ·Routine SEC 8-K filing within required timeline; no board meeting outcomes or governance details provided

18-12-2025

ImageneBio, Inc. filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to absence of key facts from the filing.

• ·Item 5.02 filing indicates officer change but specifics (e.g., CEO/CFO, appointment/resignation, reasons) are NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Sector not specified; no board composition, governance, or market impact details available.

18-12-2025

Permian Basin Royalty Trust filed an 8-K on December 18, 2025, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific proposals, vote outcomes, or quantitative details are disclosed in the provided filing summary. This is a standard mandatory disclosure with no evident financial or strategic impacts.

• ·Single-item 8-K filing under Item 5.07 (mandatory shareholder vote disclosure).
• ·No transaction values, share counts, financial metrics, or vote results mentioned (all NOT_DISCLOSED).
• ·Routine governance filing; timing compliance cannot be assessed without meeting date.

18-12-2025

Scholastic Corp filed an 8-K on December 18, 2025, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or outcomes are disclosed in the provided filing summary. Analysis is limited to filing structure; full content review required for substantive insights.

• ·8-K reports Items 2.02 and 9.01 only; multi-item filing.
• ·Core event: Disclosure of financial results; all quantitative data NOT_DISCLOSED.
• ·No revenue, earnings, guidance, or balance sheet impacts specified.

18-12-2025

F&G Annuities & Life, Inc. filed an 8-K on December 18, 2025, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the event, transaction, or financial metrics are disclosed in the filing summary. Analysis limited to disclosed items only.

• ·Specific Items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing; Item 8.01 typically voluntary
• ·Core event and quantitative data NOT_DISCLOSED

18-12-2025

Northpointe Bancshares Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements), with Item 9.01 listing exhibits. No specific details on positions, individuals, reasons, or quantitative data provided in the summary. Analysis limited to filing structure; all key facts NOT_DISCLOSED.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangements
• ·Item 9.01 references financial statements and exhibits (Size: 174 KB)
• ·No names, positions, reasons, or numerical data explicitly stated

18-12-2025

Lumexa Imaging Holdings, Inc. filed an 8-K on 2025-12-18 reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, dollar values, or financial metrics provided in the summary. Analysis limited to disclosed items; full filing required for deeper insights.

• ·Multi-item 8-K: Items 1.01, 2.03, 9.01 reported
• ·Core event: Material definitive agreement and direct financial obligation (details NOT_DISCLOSED)
• ·No quantitative data (transaction value, share count, financial metrics: all NOT_DISCLOSED)

18-12-2025

Foxx Development Holdings Inc. filed an 8-K on December 18, 2025, solely under Item 9.01 for Financial Statements and Exhibits. No core event, transaction details, or quantitative data are disclosed in the filing summary. Analysis is constrained by lack of specific content.

• ·Single-item 8-K filing reporting only Item 9.01 (Financial Statements and Exhibits).
• ·No transaction value, financial metrics, or strategic details disclosed (all NOT_DISCLOSED).
• ·Voluntary/mandatory status and filing timeliness cannot be assessed from provided information.

18-12-2025

filed SC 14D9/A on December 18, 2025 - Filed: 2025-12-18 AccNo: 0001104659-25-122532 Size: 20 KB

• ·Filing Type: SC 14D9/A
• ·Priority: MEDIUM
• ·Filed: 2025-12-18 AccNo: 0001104659-25-122532 Size: 20 KB

18-12-2025

Zoetis Inc. filed a multi-item Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 2.03), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are provided in the summary. Analysis is constrained by lack of filing content, resulting in neutral sentiment pending full review.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 7.01, 9.01 – likely mandatory disclosures
• ·Core events involve material agreement, financial obligation, and equity sales – details NOT_DISCLOSED
• ·No quantitative data (e.g., transaction value, share count) or financial impacts specified

18-12-2025

Vor Biopharma Inc. filed a multi-item Form 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), personnel changes and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and exhibits (Item 9.01). No specific transaction details, dollar values, or quantitative impacts are disclosed in the provided summary. Analysis is limited to item disclosures, indicating potential dilution and strategic shifts but lacking core event facts.

• ·Multi-item 8-K filing covering material agreement, equity sales, officer changes, and Reg FD disclosure.
• ·Mandatory items (1.01, 3.02, 5.02) suggest significant events; voluntary Reg FD (7.01).
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

21Shares Ethereum ETF filed Form 8-K on December 18, 2025 (AccNo: 0001213900-25-123294), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, or financial impacts are disclosed in the provided summary. This multi-item filing signals potentially material developments for the ETF, requiring review of the full 714 KB document.

• ·Multi-item 8-K: Items 1.01, 8.01, 9.01
• ·Core event: Entry into Material Definitive Agreement and Other Events
• ·All quantitative data (transaction value, shares, metrics): NOT_DISCLOSED

18-12-2025

Plumas Bancorp filed a Form 8-K on December 18, 2025 (AccNo: 0001437749-25-038239), reporting entry into a Material Definitive Agreement under Item 1.01 and attaching Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory disclosure of a material event, but specific details of the agreement, transaction value, or financial impacts are NOT_DISCLOSED in the provided summary. Analysis is limited without full filing content.

• ·Items reported: 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits); multi-item filing
• ·Core event: Entry into a Material Definitive Agreement (details NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED
• ·Timing and filing compliance details NOT_DISCLOSED

18-12-2025

LINKBANCORP, Inc. filed an 8-K on December 18, 2025, reporting entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item filing indicating a significant event requiring public disclosure.

• ·Items reported: 1.01 (Material Definitive Agreement), 7.01 (Reg FD Disclosure), 9.01 (Exhibits)
• ·Core event: Entry into Material Definitive Agreement (details NOT_DISCLOSED)
• ·Quantitative data: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

18-12-2025

Guidewire Software, Inc. filed an 8-K on December 18, 2025, disclosing Item 5.07 regarding submission of matters to a vote of security holders. No specific vote details, outcomes, or numerical data provided in the filing summary. This appears to be a routine shareholder meeting disclosure with limited disclosed information.

• ·Single-item 8-K filing under Item 5.07 (mandatory disclosure of shareholder vote results).
• ·No transaction values, share counts, percentages, or financial metrics mentioned (all NOT_DISCLOSED).
• ·Timing compliance and vote specifics NOT_DISCLOSED; standard post-meeting report.

18-12-2025

ONITY GROUP INC. filed a General Filing (likely 8-K) on December 18, 2025, reporting Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No details on the core event, transaction values, or financial metrics are disclosed in the provided summary. Analysis is limited to filing structure; content requires review of full document (AccNo: 0001493152-25-028354).

• ·Specific Items: 7.01 (Reg FD Disclosure, voluntary) and 9.01 (Exhibits); multi-item filing.
• ·Quantitative data (transaction value, shares, financial metrics): NOT_DISCLOSED.
• ·Core event and impacts: NOT_DISCLOSED; no facts on materiality, financials, or market expectations.

18-12-2025

Spire Inc filed an 8-K on 2025-12-18 reporting entry into a material definitive agreement (Item 1.01) that creates a direct financial obligation (Item 2.03), with financial statements and exhibits (Item 9.01). No specific details on the agreement, transaction size, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing with unknown implications due to lack of content.

• ·Reported Items: 1.01 (Material Definitive Agreement), 2.03 (Direct Financial Obligation), 9.01 (Exhibits)
• ·Multi-item 8-K filing; timing aligns with event date but business hour compliance NOT_DISCLOSED
• ·Core event involves a material agreement creating financial obligation; all quantitative data NOT_DISCLOSED

18-12-2025

KB Home filed an 8-K on December 18, 2025, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or numerical values are disclosed in the provided summary. Full filing review required for material assessment.

• ·Specific Items: 2.02 and 9.01 (multi-item filing)
• ·Core event: Financial results announcement (details NOT_DISCLOSED)
• ·All quantitative data (revenue, EPS, etc.): NOT_DISCLOSED

18-12-2025

Office Properties Income Trust filed a Form 8-K on December 18, 2025, reporting under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure to comply with Regulation FD, making previously selective information public. No specific details, numerical values, or transaction information are stated in the provided filing summary.

• ·Specific Item: 7.01 Regulation FD Disclosure
• ·Single-item filing
• ·Filed: 2025-12-18 (AccNo: 0001104659-25-122552)

18-12-2025

Tron Inc. filed an 8-K on December 18, 2025, reporting Item 5.07 on Submission of Matters to a Vote of Security Holders. No specific vote details, outcomes, or quantitative data are disclosed in the provided filing summary. This is a routine disclosure with limited actionable information.

• ·Single-item 8-K filing under Item 5.07 (mandatory for shareholder votes).
• ·Core event: Submission of matters to security holders vote; no details on proposals or results.
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED.

18-12-2025

Federal Signal Corp filed an 8-K on December 18, 2025, disclosing Other Events under Item 8.01 and Financial Statements/Exhibits under Item 9.01. No specific details on the core event, transaction value, or financial impacts are provided in the filing summary. Analysis limited to disclosed items; all quantitative data NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 8.01 (Other Events) and 9.01 (Exhibits).
• ·Core event details NOT_DISCLOSED; no dollar values, financial metrics, or strategic context provided.
• ·Timing compliance and materiality cannot be assessed without full filing content.

18-12-2025

AbCellera Biologics Inc. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the content of the disclosure or exhibits are provided in the filing summary. Analysis is limited to structural elements; core event and impacts are NOT_DISCLOSED.

• ·Multi-item 8-K filing: Items 7.01 and 9.01
• ·Regulation FD Disclosure indicates voluntary release of potentially material information
• ·Exhibits attached under Item 9.01; content NOT_DISCLOSED

18-12-2025

Cassava Sciences Inc filed an 8-K on December 18, 2025, reporting under Item 8.01 Other Events. No specific details on the core event, transaction, or financial impacts are disclosed in the provided filing summary. Analysis is limited due to absence of substantive content.

• ·Single-item filing under Item 8.01: Other Events
• ·Core event details NOT_DISCLOSED
• ·No quantitative data (e.g., transaction value, share count) mentioned

18-12-2025

Intuitive Surgical Inc filed an 8-K on 2025-12-18 under Item 5.02, indicating a potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data are explicitly stated in the provided filing summary. Analysis is constrained by lack of disclosed facts, resulting in neutral implications.

• ·Item 5.02 event: Generic disclosure on officer/director changes or compensatory arrangements; no names, positions (e.g., CEO/CFO), or reasons (e.g., retirement) specified.
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·No board meeting outcomes, succession details, or governance impacts detailed; critical information missing.

18-12-2025

Safe Pro Group Inc. filed an 8-K on December 18, 2025, under Item 8.01 Other Events (AccNo: 0001493152-25-028373). No details on the specific event, transaction, or financial impacts are provided in the filing summary. Analysis is severely limited by absence of substantive content.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Voluntary disclosure category; no other items reported
• ·No quantitative data, event details, or financial metrics disclosed

18-12-2025

CareDx, Inc. filed a Form 8-K on December 18, 2025, disclosing an event under Item 8.01 (Other Events). No details on the core event, transaction value, financial impacts, or other specifics are provided in the available filing summary. Analysis is limited to metadata, resulting in high uncertainty.

• ·Single-item 8-K filing under Item 8.01 (Other Events)
• ·Filed on 2025-12-18; timing compliance NOT_DISCLOSED
• ·All quantitative data (transaction value, shares, financial metrics) NOT_DISCLOSED

18-12-2025

Bluerock Acquisition Corp. filed an 8-K on 2025-12-18 (AccNo: 0001213900-25-123337) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties, valuation, quantitative metrics, or strategic details are explicitly stated in the provided filing summary. All key data such as transaction value, share counts, percentages, and financial metrics are NOT_DISCLOSED.

• ·Event: Merger/Acquisition announced via Item 8.01 Other Events
• ·Exhibits under Item 9.01: Financial Statements and Exhibits (contents NOT_DISCLOSED)
• ·Quantitative Data Extraction: Transaction Value NOT_DISCLOSED; Share Count NOT_DISCLOSED; Percentage Changes NOT_DISCLOSED; Financial Metrics NOT_DISCLOSED

18-12-2025

Ondas Holdings Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers), along with other events in Item 8.01 and exhibits in Item 9.01. No specific details on the officer, position, appointment/resignation, or reasons are provided in the summary. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates officer or director change, but key position (e.g., CEO/CFO) and nature (appointment/resignation) NOT_DISCLOSED.
• ·Items 8.01 and 9.01 suggest additional events and exhibits, details NOT_DISCLOSED.
• ·No board composition, succession, governance, or market impact details provided; analysis limited to filing structure.

18-12-2025

Ocugen, Inc. disclosed an officer change under Item 5.02 of Form 8-K filed on 2025-12-18, but key details including position affected, appointment/resignation status, reasons, and quantitative data are NOT_DISCLOSED. No facts on governance impact, succession, or market reaction provided. Analysis limited to filing metadata.

• ·Item 5.02: Departure/Election/Appointment of Officers or Directors; Compensatory Arrangements
• ·Filing Date: 2025-12-18 (AccNo: 0001104659-25-122610)
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

Nuburu, Inc. filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), and unregistered sales of equity securities (Item 2.03). This is a multi-item mandatory filing with exhibits under Item 9.01; no specific transaction details, values, or terms are disclosed in the provided summary.

• ·Multi-item 8-K filing covering Items 1.01, 2.03, 3.02, and 9.01.
• ·Core event involves material agreement with financial obligation and equity sales; all quantitative data (e.g., transaction value, share count) NOT_DISCLOSED.
• ·Likely financing-related transaction; critical details missing, limiting impact assessment.

18-12-2025

Iron Horse Acquisition II Corp. filed an 8-K on December 18, 2025, announcing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary. Analysis is limited; critical data such as transaction value, share counts, and financial impacts are NOT_DISCLOSED.

• ·8-K filing discloses material definitive agreement, suggesting merger/acquisition activity.
• ·Includes unregistered equity sales and governance amendments, typical for SPAC de-SPAC transactions.
• ·No quantitative data (e.g., deal value, exchange ratio) or strategic rationale provided.

18-12-2025

Air Lease Corp filed an 8-K on December 18, 2025, reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on votes, disclosures, or financial data provided in the summary. Routine shareholder meeting update combined with voluntary disclosure.

• ·Multi-item 8-K: Items 5.07, 7.01, 9.01
• ·Item 5.07 indicates shareholder vote results (routine post-meeting disclosure)
• ·Item 7.01 is Regulation FD (voluntary material info disclosure); exhibits attached under 9.01
• ·No quantitative data or transaction details disclosed

18-12-2025

Princeton Capital Corp filed an 8-K on December 18, 2025, reporting Item 5.07 on Submission of Matters to a Vote of Security Holders. No details on specific votes, outcomes, or quantitative data are disclosed in the provided summary. This appears to be a routine, single-item mandatory disclosure.

• ·Specific Item: 5.07 (Submission of Matters to a Vote of Security Holders)
• ·Single-item filing; timing compliance cannot be assessed without event date
• ·No transaction values, share counts, or financial metrics disclosed

18-12-2025

Summit Hotel Properties, Inc. filed a Form 8-K on December 18, 2025, disclosing entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). No specific transaction details, dollar values, or financial impacts are provided in the summary. Analysis is constrained by lack of explicit filing content beyond item descriptions.

• ·Multi-item 8-K filing reporting Items 1.01, 2.03, and 9.01
• ·Core event involves material definitive agreement creating financial obligation; all quantitative data (transaction value, share count, etc.) NOT_DISCLOSED
• ·Timing, compliance, and market reaction details NOT_DISCLOSED; voluntary/mandatory status tied to material event requirements

18-12-2025

NOCOPI Technologies Inc/MD/ filed an 8-K on December 18, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements of certain officers. No specific details on the officer's name, position (e.g., CEO, CFO), nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Analysis is limited to the event type and timing, with all other elements NOT_DISCLOSED.

• ·Item 5.02 filing signals officer or director change, but key position, appointment/resignation status, and reasons NOT_DISCLOSED.
• ·No quantitative data (transaction value, share count, percentages, financial metrics) mentioned: all NOT_DISCLOSED.
• ·Neutral governance implications due to lack of details on internal/external hire, succession, or board impact.

18-12-2025

F&M Bank Corp filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer/director departure, election, appointment, or compensatory arrangement
• ·Filed timely on 2025-12-18 per SEC requirements (AccNo: 0001654954-25-014119)
• ·No names, positions, reasons, or financial metrics disclosed

18-12-2025

Fidelity D & D Bancorp Inc filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual, reason for change, or quantitative data are provided in the filing summary. This appears to be a routine disclosure with neutral implications pending further details.

• ·Item 5.02 indicates officer change, but key position (e.g., CEO, CFO), appointment/resignation status, reason, and timing are NOT_DISCLOSED
• ·Item 9.01 references financial statements/exhibits, but no details or numerical values extracted
• ·Quantitative data extraction: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED
• ·No board meeting outcomes, succession details, or governance impacts specified

18-12-2025

Mercer International Inc. filed an 8-K on December 18, 2025, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific event details, financial metrics, or transaction values are disclosed in the provided filing summary. Analysis is limited to filing structure due to absence of content.

• ·Specific Items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Multi-item filing: Yes
• ·Voluntary disclosure under Reg FD; timing compliance NOT_DISCLOSED

18-12-2025

Teucrium Commodity Trust filed an 8-K on December 18, 2025, reporting amendments to articles of incorporation or bylaws/change in fiscal year under Item 5.03, with exhibits under Item 9.01. No specific details on the nature of amendments, transaction values, or financial impacts are disclosed in the provided summary. This appears to be a routine governance disclosure with low apparent materiality.

• ·Items reported: 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year) and 9.01 (Financial Statements and Exhibits); multi-item filing.
• ·Core event: Governance document amendments or fiscal year change; details NOT_DISCLOSED.
• ·No quantitative data (e.g., transaction value, share count, financial metrics) extracted; all NOT_DISCLOSED.

18-12-2025

Ulta Beauty, Inc. filed an 8-K on 2025-12-18 disclosing an officer change under Item 5.02 (Departure/Election of Officers or Compensatory Arrangements) and exhibits under Item 9.01. No details on officer name, position, appointment/resignation, reasons, or quantitative data are provided. Analysis limited to filing metadata.

• ·Item 5.02 indicates officer departure, election, appointment, or compensatory arrangement - specifics NOT_DISCLOSED.
• ·Timely SEC 8-K filing (within 4 business days requirement).
• ·No quantitative data (transaction values, shares, percentages, financial metrics: all NOT_DISCLOSED).

18-12-2025

HEICO Corp filed a Form 8-K on December 18, 2025, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or numerical values are disclosed in the provided summary. This is a standard financial results disclosure with limited available information.

• ·Specific Items reported: 2.02 and 9.01
• ·Multi-item filing for financial results
• ·Filed via US SEC on 2025-12-18; quantitative data NOT_DISCLOSED

18-12-2025

UNITED SECURITY BANCSHARES filed an 8-K on December 18, 2025, under Item 7.01 for Regulation FD Disclosure. No core event details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. Analysis is severely limited by absence of filing content.

• ·Specific Item: 7.01 (Regulation FD Disclosure); appears single-item filing
• ·Voluntary disclosure under Reg FD; timing compliance NOT_DISCLOSED
• ·All quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED

18-12-2025

ADVENT CONVERTIBLE & INCOME FUND filed an 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), with exhibits under Item 9.01. No details on the agreements, transaction values, or financial impacts are disclosed in the provided summary. This is a multi-item filing with unknown specifics.

• ·Reported Items: 1.01 (Entry into Material Definitive Agreement), 1.02 (Termination of Material Definitive Agreement), 9.01 (Financial Statements and Exhibits)
• ·Multi-item mandatory 8-K filing; timing compliance unknown
• ·Core event: Entry and termination of material agreements; all quantitative data NOT_DISCLOSED

18-12-2025

Quantum Corp filed a multi-item 8-K on December 18, 2025, reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), and submission of matters to a shareholder vote (Item 5.07). No specific transaction details, values, or outcomes are disclosed in the provided summary. Analysis limited to item descriptions; full filing required for deeper insights.

• ·Multi-item 8-K filing covering material agreement, financial obligation, equity sales, and shareholder vote.
• ·Suggests potential transaction involving financing, dilution, and approvals; all quantitative data NOT_DISCLOSED.
• ·Filed as Material Event, indicating high regulatory significance but directional impact unclear.

18-12-2025

Shift4 Payments, Inc. filed an 8-K on December 18, 2025, reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.02 (Departure/Election of Directors/Officers or Compensatory Arrangements). No specific details on the agreement, personnel changes, or financial terms are disclosed in the provided summary. This multi-item filing indicates material events but lacks quantitative data for impact assessment.

• ·Multi-item 8-K filing: Items 1.01 and 5.02.
• ·Core events: Material definitive agreement and officer/director changes or comp arrangements.
• ·All transaction values, share counts, financial metrics: NOT_DISCLOSED.

18-12-2025

BlackBerry Ltd filed a Form 8-K on December 18, 2025, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This is a standard earnings-related disclosure with limited details available.

• ·Reported Items: 2.02 and 9.01 only; multi-item filing focused on financial results.
• ·No quantitative data (revenue, EPS, etc.) or transaction details disclosed.
• ·Filing appears compliant with SEC 8-K timelines based on date provided, but specifics NOT_DISCLOSED.

18-12-2025

Tvardi Therapeutics, Inc. filed a Form 8-K on December 18, 2025 (AccNo: 0001104659-25-122615), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data (e.g., transaction values, share counts) are stated in the provided summary—all marked as NOT_DISCLOSED. Analysis is limited to filing facts, with no board outcomes, succession details, or market reactions disclosed.

• ·Item 5.02 disclosure for officer change, filed within SEC 4-business-day requirement
• ·No facts on key position (CEO/CFO/COO etc.), internal/external hire, or reasons provided
• ·No quantitative data (shares, values, percentages) or governance impacts extracted—ALL NOT_DISCLOSED

18-12-2025

CID Holdco, Inc. filed an 8-K on December 18, 2025, disclosing an officer change under Item 5.02, Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; critical details NOT_DISCLOSED.

• ·Item 5.02 triggered: Indicates departure, election, or appointment of officers/directors, but specifics NOT_DISCLOSED.
• ·Item 7.01: Regulation FD disclosure filed, content NOT_DISCLOSED.
• ·Item 9.01: Financial statements/exhibits attached, details NOT_DISCLOSED.

18-12-2025

Virgin Galactic Holdings, Inc. filed a Form 8-K on December 18, 2025, reporting under Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing indicating a significant transaction involving agreements, financial obligations, and equity issuances. No specific details on transaction terms, values, or impacts are disclosed in the provided summary.

• ·Multi-item 8-K filing: Items 1.01, 2.03, 3.02, 9.01
• ·Core event involves material agreement, financial obligation, and unregistered equity sales (exact nature NOT_DISCLOSED)
• ·All quantitative data (transaction value, share count, financial metrics) NOT_DISCLOSED